A long-acting GHRH analog for sustained GH axis research. CJC-1295 with DAC (Drug Affinity Complex) is modified for extended half-life, studied for its ability to produce sustained elevation of GH and IGF-1 levels in research models.
Key Research Areas
Extended half-lifeSustained GH elevationIGF-1 modulationGHRH research
Molecular Information
| Dosage | 5mg per vial |
| Purity | 99%+ (HPLC & MS Verified) |
| Format | Lyophilized powder |
| Storage | Store at -20°C. Stable at room temperature for short-term shipping. |
| Reconstitution | Reconstitution Solution (for research use only) |
| Verification | NFC Blockchain Tag included |
CJC-1295 — w/ DAC is a research compound with a growing body of published literature examining its biological activity and mechanisms of action. The research summaries below are derived from publicly available peer-reviewed studies and are provided for informational purposes only.
Research Focus Areas
Extended half-lifeSustained GH elevationIGF-1 modulationGHRH research
Published research on CJC-1295 — w/ DAC spans multiple model systems and research frameworks. Studies have examined mechanisms at the molecular, cellular, and systemic levels. Researchers are encouraged to access primary literature through PubMed and peer-reviewed databases.
Research Disclaimer: The research summaries provided are for informational purposes only and are based on publicly available scientific literature. We do not make medical or therapeutic claims. These statements have not been evaluated by the FDA.
Every batch of CJC-1295 — w/ DAC is independently tested and shipped with a Certificate of Analysis documenting purity, identity, batch number, and testing methodology.
Testing Specifications
| Testing Method | HPLC + Mass Spectrometry |
| Purity Standard | 99%+ |
| Lab | Third-party independent laboratory (USA 🇺🇸) |
